The goal of our lab is to understand genetic circuits that control human immune cell function in health and disease, employing powerful new CRISPR genome engineering technologies. We are focused on elucidating the genetic and epigenetic regulation of human immune cells and the development and application of gene editing technologies to manipulate immune cells to fight diseases including cancer, autoimmunity, and infectious disease. The lab is decoding gene programs in pro-inflammatory T cells that drive effective anti-cancer immune responses and programs in anti-inflammatory regulatory T cells (Tregs) that are critical to prevent autoimmunity. Using tools developed in the lab for CRISPR genome engineering in primary human T cells we are pursuing a comprehensive strategy to test how coding and non-coding genetic variation controls functional programs in the immune system and extending our genome engineering capabilities to reprogram the next generation of cellular therapies.
The Marson lab is a team of highly collaborative students, research technicians, and postdoctoral scientists with expertise across the fields of genomics, immunology, infectious diseases and genome engineering.
Recent Lab News
Zach Steinhart was selected for the Parker Scholar award from the Parker Institute for Cancer Immunotherapy.
Ujjwal Rathore was awarded the Mathilde Krim fellowship by The Foundation for AIDS Research (amfAR).
Tori Yamamoto has been appointed a Zena Werb scholar as a T32 trainee.
The Marson lab has moved into space at the new Gladstone-UCSF Institute of Genomic Immunology.
Alex is featured on 60 minutes to discuss COVID-19 antibody testing.
Alex is named Director of the newly launching Gladstone-UCSF Institute of Genomic Immunology.